2.1 SpO
2
Monitoring
72
2.1.4. SpO
2
Monitoring using Masimo SET
®
technology
Description
This section provides information on how to operate a device equipped with a pulse oximetry
module using Ma
simo SET® technology (MS-2040) to monitor:
saturation of arterial blood with oxygen, SpO
2
photoplethysmogram, PPG
heart rate obtained from photoplethysmogram, PR
perfusion (filling) index - the numerical value of the pulsating component of the regis-
tered signal due to the pulsation of arterial blood flow, PI.
Masimo
®
, Masimo SET
®
, LNOP
®
, LNCS
®
are registered trademarks of Masimo Corporation, USA
If the device is equipped with the pulse oximetry module using Masimo SET
®
technology, the side panel of the connectors has a special rectangular con-
nector marked with a special sign.
Operating principle
The principle of operation of the Masimo SET® pulse oximetry module, like a conventional
pulse oximeter, is based on different spectral absorption of oxyhemoglobin and reduced blood
hemoglobin. The pulsating blood in the tissue is illuminated by radiation sources in the red and
infrared spectrum, and the received signals, after appropriate processing, make it possible to
determine the modulation coefficients of these light fluxes and, by their ratio, determine the oxy-
gen saturation of blood hemoglobin, while the modulation frequency corresponds to the pulse
rate. The difference between Masimo SET® technology lies in the additional mathematical pro-
cessing of signals received in the red and infrared spectrum in order to compensate for interfer-
ence from light absorption by venous blood.
Patents
Masimo SET
®
technology protected by the respective patents listed on the website
No Implied License
Possession or purchase of this device does not convey any express or implied license to use
the device with unauthorized sensors or cables which would, alone or in combination with this
device, fall within the scope of one or more of the patents relating to this device.
WARNINGS!
Explosion hazard. Do not use the device in the presence of flammable anesthetics or other
flammable substance in combination with air, oxygen-enriched environments, or nitrous ox-
ide.
The device is to be operated by qualified personnel only. This manual, accessory directions
for use, all precautionary information, and specifications should be read before use.
The device should NOT be used as an apnea monitor.
Pulse rate measurement is based on the optical detection of a peripheral flow pulse and
therefore may not detect certain arrhythmias. The pulse oximeter should not be used as a
replacement or substitute for ECG based arrhythmia analysis.
A pulse oximeter should be considered an early warning device. As a trend towards patient
deoxygenation is indicated, blood samples should be analyzed by a laboratory co-oximeter to
completely understand the patient’s condition.
Electric shock hazard. Do not remove the device cover. An operator may only perform
maintenance procedures specifically described in this manual. Refer servicing to the service
center in repair of this equipment.
Summary of Contents for MPR6-03
Page 1: ...Patient Monitor MPR6 03 User Manual RM 501 01 000 01 01 UM Version 7 05 2020 ...
Page 2: ...2 ...
Page 193: ...193 ...